Welcome to LookChem.com Sign In|Join Free

CAS

  • or
beta-D-erythro-Pentofuranoside, methyl 2-amino-2,3-dideoxy- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

689221-47-4

Post Buying Request

689221-47-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

689221-47-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 689221-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,9,2,2 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 689221-47:
(8*6)+(7*8)+(6*9)+(5*2)+(4*2)+(3*1)+(2*4)+(1*7)=194
194 % 10 = 4
So 689221-47-4 is a valid CAS Registry Number.

689221-47-4Downstream Products

689221-47-4Relevant articles and documents

β-Methyl-2-amino-2,3-didesoxyribofuranoside, a Novel Building Block for Backbone Modified Antisense Oligonucleotides

Winkler, Johannes,Urban, Ernst,Noe, Christian R.

, p. 109 - 116 (2007/10/03)

A synthesis of the amino sugar 2-amino-2,3-didesoxyribose is described. Starting from D-glucosamine, β-methylfuranoside was obtained in eight steps in 20% yield. This carbohydrate is a novel building block for nucleosides and for backbone modified antisense oligonucleotides with 2′-5′ amide linkages.

Structural modifications of antisense oligonucleotides

Urban, Ernst,Noe, Christian R.

, p. 243 - 258 (2007/10/03)

Antisense oligonucleotides are efficient tools for the inhibition of gene expression in a sequence specific way. Natural oligonucleotides are decomposed rapidly in biological systems, which strongly restrict their application. In contrast, artificial oligonucleotides are designed to be more stable against degradation than the target mRNA, which results in a catalytic effect of the drug. Modification of the phosphate linkage has been the first successful strategy for antisense drug developments and Fomivirsene the first antisense drug in therapy. The launch of Fomivirsene has resulted in a revolutionary spin off to antisense research leading to a second generation of antisense oligonucleotides, which are stable against oligonucleotide cleaving enzymes. Among these, oligonucleotides bearing an alkoxy substituent in position 2′ were the most successful ones. The third generation of antisense oligonucleotides contains structure elements, which enhance the antisense action. Zwitterionic oligonucleotides show remarkable results, first, because the stability against ribozymes is largely increased, and secondly, because the electrostatic repulsion between the anionic sense and the zwitterionic antisense cords is minimized. Promising new target molecules in antisense reseach are oligonucleotide chimaeres, which enhance the antisense action (chimaeres with intercalators, chelators or polyamines) or enable an application as sequence specific detectors (chimaeres with biotin, fluorescein or radioligands).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 689221-47-4